Medtronic PLC (MDT)
84.74
+0.63
(+0.75%)
USD |
NYSE |
Nov 21, 16:00
84.76
+0.02
(+0.02%)
Pre-Market: 08:21
Medtronic Enterprise Value: 129.24B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 129.24B |
| November 20, 2024 | 128.43B |
| November 19, 2024 | 129.58B |
| November 18, 2024 | 132.90B |
| November 15, 2024 | 132.82B |
| November 14, 2024 | 130.86B |
| November 13, 2024 | 133.39B |
| November 12, 2024 | 133.81B |
| November 11, 2024 | 133.77B |
| November 08, 2024 | 133.06B |
| November 07, 2024 | 133.58B |
| November 06, 2024 | 136.13B |
| November 05, 2024 | 135.58B |
| November 04, 2024 | 135.10B |
| November 01, 2024 | 136.08B |
| October 31, 2024 | 135.03B |
| October 30, 2024 | 136.25B |
| October 29, 2024 | 136.02B |
| October 28, 2024 | 136.38B |
| October 25, 2024 | 136.37B |
| October 24, 2024 | 136.89B |
| October 23, 2024 | 138.53B |
| October 22, 2024 | 137.05B |
| October 21, 2024 | 136.94B |
| October 18, 2024 | 138.49B |
| Date | Value |
|---|---|
| October 17, 2024 | 135.35B |
| October 16, 2024 | 135.60B |
| October 15, 2024 | 135.41B |
| October 14, 2024 | 135.63B |
| October 11, 2024 | 134.80B |
| October 10, 2024 | 134.14B |
| October 09, 2024 | 133.50B |
| October 08, 2024 | 133.23B |
| October 07, 2024 | 131.82B |
| October 04, 2024 | 133.39B |
| October 03, 2024 | 132.76B |
| October 02, 2024 | 134.49B |
| October 01, 2024 | 135.62B |
| September 30, 2024 | 135.66B |
| September 27, 2024 | 134.74B |
| September 26, 2024 | 134.91B |
| September 25, 2024 | 134.83B |
| September 24, 2024 | 135.31B |
| September 23, 2024 | 135.44B |
| September 20, 2024 | 134.77B |
| September 19, 2024 | 134.94B |
| September 18, 2024 | 133.22B |
| September 17, 2024 | 133.86B |
| September 16, 2024 | 135.76B |
| September 13, 2024 | 135.62B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
109.59B
Minimum
Oct 27 2023
197.40B
Maximum
Sep 08 2021
146.48B
Average
138.23B
Median
Aug 22 2022
Enterprise Value Benchmarks
| Boston Scientific Corp | 143.48B |
| Axonics Inc | 3.283B |
| TransMedics Group Inc | 2.841B |
| Inari Medical Inc | 2.801B |
| Agilent Technologies Inc | 39.10B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.27B |
| Revenue (Quarterly) | 8.403B |
| Total Expenses (Quarterly) | 6.779B |
| EPS Diluted (Quarterly) | 0.99 |
| Gross Profit Margin (Quarterly) | 64.94% |
| Profit Margin (Quarterly) | 15.11% |
| Earnings Yield | 3.86% |
| Operating Earnings Yield | 5.18% |
| Normalized Earnings Yield | 4.101 |